A detailed history of Jacobson & Schmitt Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jacobson & Schmitt Advisors, LLC holds 2,487 shares of MRK stock, worth $247,506. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,487
Previous 2,524 1.47%
Holding current value
$247,506
Previous $312,000 9.62%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$111.15 - $128.97 $4,112 - $4,771
-37 Reduced 1.47%
2,487 $282,000
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $312,471 - $335,591
2,524 New
2,524 $312,000
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $18,332 - $19,950
-183 Reduced 8.2%
2,050 $223,000
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $18,839 - $20,922
183 Added 8.93%
2,233 $229,000
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $211,027 - $235,463
2,050 New
2,050 $218,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jacobson & Schmitt Advisors, LLC Portfolio

Follow Jacobson & Schmitt Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobson & Schmitt Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobson & Schmitt Advisors, LLC with notifications on news.